Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Progenics Pharmaceuticals Inc (PGNX_old)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Progenics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Progenics historical data, for real-time data please try another search
4.10 0.00    0.00%
19/06 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 4.24 / 4.35
  • Day's Range: 3.94 - 4.79
Progenics 4.10 0.00 0.00%

PGNX_old Recent Sentiments

 
This page contains information on users’ sentiments for the Progenics Pharmaceuticals Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jun 26, 2020 Paolo Magnani   4.10 Jul 17, 2020 @ 4.10 0.00%
May 29, 2020 Pablo Gomez   4.20 Jun 19, 2020 @ 4.10 -2.38%
May 25, 2020 gar fil   3.96 May 27, 2020 @ 4.20 +6.06%
May 18, 2020 Paolo Magnani   3.97 Jun 12, 2020 @ 4.04 +1.76%
May 14, 2020 Andrei V Belyi   3.40 Jun 05, 2020 @ 4.51 -32.79%
Apr 14, 2020 Paolo Magnani   4.02 May 08, 2020 @ 3.92 -2.49%
Mar 20, 2020 Paolo Magnani   2.25 Apr 10, 2020 @ 3.69 -64.00%
Feb 21, 2020 Paolo Magnani   5.12 Mar 13, 2020 @ 3.15 -38.48%
Feb 13, 2020 Esee Dupas   4.70 Mar 06, 2020 @ 4.53 +3.62%
Jan 23, 2020 Paolo Magnani   4.75 Feb 14, 2020 @ 4.61 +2.95%
Jan 13, 2020 Esee Dupas   4.67 Feb 07, 2020 @ 4.62 +1.07%
Dec 19, 2019 Paolo Magnani   5.30 Jan 10, 2020 @ 4.78 -9.81%
Nov 22, 2019 Carlos Castro   5.17 Dec 13, 2019 @ 5.01 -3.09%
Oct 21, 2019 Riccardo Ferri   5.08 Nov 15, 2019 @ 5.75 +13.19%
Oct 04, 2019 Esee Dupas   5.69 Oct 25, 2019 @ 4.98 +12.48%
Sep 12, 2019 Eleftherios Kostas   5.50 Oct 04, 2019 @ 5.67 +3.09%
Sep 10, 2019 Giacomo Ambrosini   5.11 Oct 04, 2019 @ 5.67 +10.96%
Sep 10, 2019 Ziv Kushnir   5.01 Oct 04, 2019 @ 5.67 +13.17%
Aug 29, 2019 Andrei V Belyi   4.50 Sep 20, 2019 @ 5.24 +16.44%
Aug 22, 2019 Robbert Kuipers   4.33 Sep 13, 2019 @ 5.35 +23.56%
Aug 14, 2019 Esee Dupas   3.80 Sep 06, 2019 @ 4.84 +27.40%
Aug 09, 2019 宏 王   4.68 Aug 30, 2019 @ 4.40 +6.08%
Jul 29, 2019 Esee Dupas   5.12 Aug 14, 2019 @ 3.79 +26.07%
Jul 25, 2019 maor Ye   5.14 Aug 16, 2019 @ 3.70 -28.02%
Jul 24, 2019 Eleftherios Kostas   5.08 Aug 16, 2019 @ 3.70 -27.17%
Jun 28, 2019 Dan Bohnenstiehl   6.16 Jul 19, 2019 @ 5.26 -14.61%
Jun 21, 2019 Andrei V Belyi   5.18 Jul 12, 2019 @ 5.64 -8.78%
Jun 20, 2019 bernard welvaert   5.02 Jul 03, 2019 @ 5.84 +16.33%
Jun 18, 2019 bernard welvaert   4.60 Jun 20, 2019 @ 4.99 -8.37%
Jun 14, 2019 Eleftherios Kostas   4.14 Jul 05, 2019 @ 5.86 +41.55%
May 07, 2019 bernard welvaert   5.43 May 31, 2019 @ 4.19 -22.84%
Apr 24, 2019 Esee Dupas   5.00 May 17, 2019 @ 4.65 -7.00%
Apr 23, 2019 Marc Vrijken   5.06 May 17, 2019 @ 4.65 -8.10%
Apr 23, 2019 Suzanne Lindgren   4.92 May 17, 2019 @ 4.65 -5.49%
Apr 11, 2019 László Bátki   5.11 May 03, 2019 @ 5.28 +3.33%
Mar 20, 2019 Erik Dennison   4.53 Apr 12, 2019 @ 5.26 +16.11%
Feb 04, 2019 Ziv Kushnir   4.73 Mar 06, 2019 @ 4.13 -12.68%
Jan 25, 2019 gar fil   4.62 Feb 24, 2019 @ 4.46 -3.57%
Jan 04, 2019 Austin Cooper   4.30 Feb 04, 2019 @ 6.69 +55.65%
Dec 12, 2018 Estefania Juste   5.20 Jan 11, 2019 @ 6.69 +28.65%
Nov 28, 2018 Denis Thériault   5.02 Dec 28, 2018 @ 6.69 +33.27%
Oct 31, 2018 Antonio Estepa   5.07 Nov 30, 2018 @ 6.69 +32.08%
Oct 16, 2018 Tamás Wehring   5.51 Nov 15, 2018 @ 6.69 +21.46%
Sep 20, 2018 Matt Fennema   6.36 Oct 20, 2018 @ 6.69 +5.27%
Sep 19, 2018 Ziv Kushnir   6.29 Oct 19, 2018 @ 6.69 +6.36%
Sep 17, 2018 Tamás Wehring   5.77 Sep 25, 2018 @ 6.45 +11.79%
Sep 13, 2018 Ivan Dimitrov   6.21 Oct 13, 2018 @ 6.69 +7.82%
Aug 31, 2018 Andrei V Belyi   7.80 Sep 30, 2018 @ 6.27 +19.62%
Aug 30, 2018 Tamás Wehring   7.91 Sep 08, 2018 @ 7.36 -6.95%
Aug 15, 2018 Ziv Kushnir   7.69 Sep 14, 2018 @ 5.62 -26.98%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PGNX_old Comments

Write your thoughts about Progenics Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Luc Apers
Luc Apers Aug 01, 2018 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Despite good news, nothing really moves .... Strange ???
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email